Real-time enrollment status for this major bleeding clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:33 AM UTC
| NCT Number | NCT04867837 |
| Recruiting Status | Recruiting |
| Condition | Major Bleeding |
| Phase | Clinical Trial |
| Target Enrollment | 260 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Octapharma |
| Last Updated on CT.gov | November 12, 2025 (Nov 12, 2025) |
As of March 2, 2026: Clinical trial NCT04867837 is currently recruiting participants. This clinical trial study for major bleeding is actively seeking new participants at 10 locations across the United States. The study is sponsored by Octapharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04867837 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04867837 was last updated Nov 12, 2025 (November 12, 2025). HelloStudys verifies this status automatically.